ch 44 Flashcards
Risk for atherosclerotic cardiovascular disease (ASCVD) is directly related to
increased levels of LDLs (low-density lipoproteins)
The preferred method for lowering LDL is
modification of diet combined with exercise. Drugs employed when this is not sufficient
good cholesterol
HDL
when we want to reduce cholesterol levels, it is more important to
reduce intake of saturated fats as opposed to reducing intake of cholesterol itself
VLDLs contain mainly
triglycerides (unclear of the link) - probably contribute to atherosclerosis
VLDL increases risk for
pancreatitis
HDLs promote
cholesterol removal by getting them from tissues to liver
approved for treating dyslipidemia in children and adolescents
lovastatin
atorvastatin
pravastatin
simvastatin
avoid in children younger than 10
“These kids need to run some laps”
approved for treating dyslipidemia in pregnant
no
Ezetimibe (Zetia) and fibrates can be used but benefit outweigh risk
approved for treating dyslipidemia in breastfeeding
not studied in this group
same as pregnancy
approved for treating dyslipidemia in older adults
in pt 65 and old, statins significantly reduced risk for stroke . take cost into consideration
what tool is used to categorize risk for ASCVD
Framingham risk prediction score
what factors is considered in the Framingham risk prediction score
age total cholesterol HDL smoking status systolic BP
The ACC/AHA cholesterol guidelines defines high ASCVD risk as
20% or more
The ACC/AHA cholesterol guidelines defines very high risk are pt with
existing clinical ASCVD
To assess ASCVD risk we need what info
1) Identify ASCVD risk factors
2) Calculate 10 yr ASCVD risk
3) Identify ASCVD risk equivalents
low intensity statin therapy options
daily dose lowers LDL-C on average <30%
Pravastatin: 10-20mg
Lovastatin: 20mg
Simvastatin: 10mg
(PLS let this work)
Moderate intensity therapy
daily dose lowers LDL-C on average <30% to <50%
Lovastatin: 40mg Atorvastatin: 10mg Pravastatin: 40mg Simvastatin: 20-40mg Rosuvastatin: 10mg
(LAPS-R for mod)
High intensity therapy
daily dose lowers LDL-C on average > equal to 50%
Atorvastatin 40-80mg
Rosuvastatin: 20mg
(RA)
Therapeutic lifestyle therapy for hyperlipidemia
diet
exercise
weight control
smoking cessation
how long is statin treatment
lifelong
what drug class is most effective agent for hyperlipidemia
HMG-CoA reductase inhibitors (statins)
metabolic syndrome (syndrome x)
metabolic abnormalities associated increased r/o ASCVD Type 2DM high blood gludcose high TGs high apolipoprotein B low HDL small LDL particles prothrombotic state proinfammatory state HTN
diagnostic criterion for metabolic syndrome
3 or more
High TG levels - 150 or higher
low HDL - below 40 for men or below 50 for women
hyperglycemia - fasting blood glucose 100+
High BP - systolic 130+ diastolic 85+
waist circumference 40in plus men
35 in plus women
treatment goal for metabolic syndrome
reducing risk for atherosclerosis
reducing risk of type 2 DM
med goals for metabolic syndrome
lower BP and TG levels
should take low dose ASA to reduce r/o thrombosis unless at risk for intracranial bleeds
high triglyceride levels are associated with
metabolic syndrome inactive lifestyle cigarette smoking excessive alcohol type 2 dm certain genetic disorders high carb intake (>60% of caloric intake)
how do you treat high TG
diet mods
statins
if still remain high fibrates may be needed
when fibrates are combined with statins, the adverse effects of cholesterol lowering agents may
be intensified
most effective drugs for lowering LDL and total cholesterol They can raise HDL and lower TGs in some pts
HMG coA reductase inhibitors (Statins)
How long does it take to statins to work
significant within 2 weeks
max within 4-6 weeks
serum cholesterol levels will return if you stop taking med. This is lifelong.
Low levels of HDL
below 40 mg/dL
goal is to raise levels of HDL to
50 mg/dL or more
Do we prescribe statins to lower TGs
No, but it is a good side effect that has been documented
Statins also help with
reducing the risk for CV events such as
risk for a-fib risk for thrombosis stabilizes plaque reducing inflammation suppresses production of thrombin (key factor in clot formation
what statin is approved for reducing the risk for CV events in people with normal levels of LDL and no clinically evident ASCVD but do have an increased risk based on advancing age, high levels of CRP and at least one other risk factor for CV disease such as HTN , Low HDL or LDL
rosuvastatin (crestor)
For many pt the goal is to drop LDL cholesterol to below
100mg/dL